why should i use cryptocurrency Top Block

In good financial conditionAccording to the research report of Huasheng Securities, Jinhe Bio expects the net profit of returning to its mother in 2024-2026 to be 2.07/2.92/391 million yuan, corresponding to the pe(ttm) of 18.57/13.15/9.83x, while the average predicted PE (TTM) of comparable companies in 24-26 years is 23.46/18.89/11, respectively.The valuation advantage is obvious.

According to the research report of Huasheng Securities, Jinhe Bio expects the net profit of returning to its mother in 2024-2026 to be 2.07/2.92/391 million yuan, corresponding to the pe(ttm) of 18.57/13.15/9.83x, while the average predicted PE (TTM) of comparable companies in 24-26 years is 23.46/18.89/11, respectively.-Steady growth in performance: in the first three quarters of 2024, the company achieved operating income of 1.657 billion yuan, up 5.57% year-on-year; The net profit returned to the mother was 114 million yuan, up 10.38% year-on-year, and the net profit returned to the mother in the third quarter increased 65.92% year-on-year, showing an obvious growth trend.

-Improvement of profitability: In the first half of 2024, the overall gross profit margin was 33.3%, up by 3.4 percentage points year-on-year, and the net cash flow from operating activities reached 170 million yuan, up by 90.04% year-on-year, indicating that the company's profitability and cash flow were in good condition.-Accelerating the pace of internationalization: The company has established a sales network for veterinary chemicals that radiates to key global markets, and the sales revenue in overseas markets continues to rise, and the sales network for veterinary chemicals has been extended to veterinary vaccines, which has exerted a synergistic effect. In the future, overseas markets are expected to continue to expand and promote performance growth.-Improvement of profitability: In the first half of 2024, the overall gross profit margin was 33.3%, up by 3.4 percentage points year-on-year, and the net cash flow from operating activities reached 170 million yuan, up by 90.04% year-on-year, indicating that the company's profitability and cash flow were in good condition.